Zhejiang Shengyang Science Capital Reinvestment Ratio
Zhejiang Shengyang Science capital reinvestment ratio. Zhejiang Shengyang Science (603703) has a Capital Reinvestment Ratio of 1.96x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥8.25 Million) in capital expenditures (CN¥16.20 Million). See Zhejiang Shengyang Science free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhejiang Shengyang Science (2012–2025)
Capital reinvestment ratio of Zhejiang Shengyang Science from 2012 to 2025. This chart tracks Zhejiang Shengyang Science's Capital Reinvestment Ratio across 12 annual periods. See 603703 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Zhejiang Shengyang Science Capital Reinvestment Ratio by Year (2012–2025)
Zhejiang Shengyang Science capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see Zhejiang Shengyang Science (603703) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.94x | CN¥39.15 Million | CN¥75.94 Million | ▲ +51.7% |
| 2023 | 1.28x | CN¥81.30 Million | CN¥103.97 Million | ▲ +11.4% |
| 2022 | 1.15x | CN¥89.94 Million | CN¥103.28 Million | ▼ -1.6% |
| 2021 | 1.17x | CN¥76.14 Million | CN¥88.88 Million | ▲ +29.7% |
| 2020 | 0.90x | CN¥55.06 Million | CN¥49.53 Million | ▲ +42.3% |
| 2019 | 0.63x | CN¥52.25 Million | CN¥33.04 Million | ▲ +35.2% |
| 2018 | 0.47x | CN¥62.76 Million | CN¥29.36 Million | ▲ +98.3% |
| 2017 | 0.24x | CN¥129.96 Million | CN¥30.65 Million | ▼ -62.1% |
| 2016 | 0.62x | CN¥33.70 Million | CN¥20.97 Million | ▼ -6.9% |
| 2014 | 0.67x | CN¥66.34 Million | CN¥44.34 Million | ▼ -26.1% |
| 2013 | 0.90x | CN¥48.66 Million | CN¥43.98 Million | ▼ -81.4% |
| 2012 | 4.86x | CN¥4.85 Million | CN¥23.56 Million | — |